Expert Trading Insights

Unlock the secrets of successful trading with guidance tailored for traders of all levels.

Your Daily Dose of the Doctor

Market Trends

Stay updated with the latest shifts and patterns in the trading world.

Trading Strategies

Discover proven strategies to enhance your trading performance.

Risk Management

Learn techniques to effectively manage and mitigate trading risks.

Technical Analysis

Master the art of analyzing charts and market data for better trades.

Economic Indicators

Understand the impact of economic indicators on market movements.

Trading Psychology

Develop the mindset needed for successful trading.

Trading Discipline

Learn to check all the boxes and trade with the precision required for profits.

News & Updates

Get the latest news and updates impacting the trading landscape.

Latest Articles

Drug Pricing Uncertainty

Drug Pricing Uncertainty Keeps a Lid on Pharma Stocks TraderInsight • September 2025 • Pharma, Tariffs, Policy The Trump administration’s 100% tariffs on foreign-made drugs sounded harsh. In reality, Big Pharma can live with them. What the sector can’t shake is drug...

read more

Perpetual Futures Trading

Perpetual Futures Trading: Why ‘Perps’ Are Driving a New Speculation Boom TraderInsight • September 2025 • Crypto, Leverage, Derivatives Crypto traders are rushing into perpetual futures trading, contracts known as “perps” that allow investors to apply leverage of 10,...

read more

Day Trading Margin Rule Change

Day Trading Margin Rule Change: What It Means for Retail Traders TraderInsight • September 24, 2025 • FINRA, SEC, PDT For over two decades, retail traders have been operating under the shadow of the Pattern Day Trader rule. If your account dropped below $25,000, you...

read more

Alibaba AI Spending Rally

Alibaba AI Spending Rally: Why the Stock Could Climb Even Higher TraderInsight • September 24, 2025 • BABA, AI, China Tech Alibaba (BABA) shares jumped 10% after the company announced new AI spending, overseas data centers, and the unveiling of Qwen3-Max, its...

read more

Nvidia AI Backstop

Nvidia AI Backstop: Trader’s Playbook for the AI Ecosystem TraderInsight • September 2025 • NVDA, AI Infrastructure, Market Strategy Nvidia’s $100 billion deal with OpenAI reinforces its role as the Nvidia AI backstop — a financing partner to secure chip demand and...

read more

Stock Market Overvaluation

Is the Stock Market Overvalued? What Traders Should Watch Next TraderInsight • September 22, 2025 • S&P 500, Fed, Valuations The S&P 500 has set 28 record highs this year and sits near 6,664. But valuations are stretched to dot-com era levels, making many...

read more

Powell Speech Market Selloff

Powell Speech Market Selloff: Why Stocks Dropped After Fed Remarks TraderInsight • Today • Federal Reserve, Markets, Equities Stocks fell sharply today after Federal Reserve Chairman Jerome Powell delivered a speech that rattled investor confidence. The Powell speech...

read more

Nvidia China Trade War September 2025

Nvidia China Trade War September 2025: Beijing Blacklists RTX Pro 6000D China expands restrictions on Nvidia’s AI chips, intensifying trade war dynamics with the United States. Beijing Targets Nvidia’s Latest AI Chip The Nvidia China trade war September 2025 reached a...

read more

TikTok US-China Deal

TikTok US-China Deal: Beijing Confirms Algorithm Use as Trump Extends Deadline TraderInsight • September 2025 • Tech, Social Media, Geopolitics Beijing has confirmed that TikTok’s U.S. app will continue to run on its Chinese-developed algorithm, even as Washington...

read more

Fed Rate Decision and Dot Plot

The Federal Reserve heads into this week’s policy meeting with a crowded agenda and a rare layer of political drama. On Wednesday, the FOMC will unveil its policy statement alongside fresh economic projections and the quarterly grid of rate expectations. Markets are...

read more

Fed Rate Cut Trading Strategy

Fed Rate Cut Trading Strategy: Stocks and Sectors to Watch The Fed is expected to cut rates by 1.5 percentage points over the next year. But not all cuts are bullish for all stocks. How the 2-year yield reacts will dictate whether traders lean into growth, cyclicals,...

read more

Novo Nordisk Job Cuts

Novo Nordisk Job Cuts: 9,000 Roles Axed as Pharma Giant Restructures September 10, 2025 • Healthcare, Pharma, Markets Danish drugmaker Novo Nordisk, maker of the blockbuster weight-loss drug Wegovy, is embarking on a major restructuring under new CEO Maziar Mike...

read more

Lumber Prices Warning Sign

Lumber Prices Are Flashing a Warning Sign for the U.S. Economy TraderInsight • September 9, 2025 • Macro, Housing, Materials Lumber futures have fallen roughly a quarter from early August highs, even as major producers announce output cuts. In past cycles, this type...

read more

Biotech Stocks Year-End Rally

Biotech’s Breakout: Trading XBI Leaders into Year-End Biotech just put up a statement week: the SPDR S&P Biotech ETF (XBI) gained 6% while the broader healthcare ETF (XLV) slipped ~0.8%. When this corner of the market leads, risk appetite is usually...

read more

Lowe’s Housing Rebound

Lowe’s CEO Marvin Ellison Prepares for Housing Rebound Sept 4, 2025 • Based on Barron’s interview with Marvin Ellison Overview Lowe’s CEO Marvin Ellison is positioning the company to seize growth when U.S. housing demand rebounds. Despite today’s sluggish home...

read more

Broadcom AI Order

Broadcom Beats, Lands a New AI Customer — What It Means for Traders At a Glance Fiscal Q3 Revenue $15.95B (beat) Adj. EPS $1.69 (beat) Q4 Revenue Guide $17.4B (above consensus) AI Revenue Trend +63% YoY to ~$5.2B in Q3; mgmt sees further Q4 growth Stock Action Closed...

read more

CDC Turmoil And Vaccine Stocks

CDC Shake-Up Puts Vaccine Trades in Play Washington’s overhaul of the nation’s public-health apparatus is no longer background noise—it’s a live catalyst for vaccine names. This piece explains how CDC turmoil and vaccine stocks intersect with trading tactics you can...

read more

Figma Earnings Miss

Figma earnings miss: What traders need to know now Figma’s first report as a public company came in hot on revenue growth—but cool on expectations—sending shares sharply lower after hours. Below is the fast read for day-traders and swing-traders, followed by deeper...

read more

Alphabet Antitrust Ruling

Alphabet antitrust ruling sends shares to a record high A federal judge issued targeted remedies in the Google search case—no breakup, no ban on default-search payments—fueling a sharp rally in Alphabet and a relief pop in Apple. Updated September 3, 2025 Alphabet...

read more

India Russian Oil US Tariffs

India Holds Firm on Russian Oil as US Tariff Threats Loom Key Developments The Trump administration is preparing to impose punitive tariffs of up to 50% on Indian exports in response to New Delhi’s ongoing purchases of Russian crude oil. A planned US trade delegation...

read more

Tesla Stock Rises

Tesla Stock Rises: Why Day Traders Should Be Cautious After Gains Tesla stock rises again, notching its third straight day of gains and closing at $351.67—its highest since late May. The move follows a 6.2% surge on Friday after Fed Chair Jerome Powell’s Jackson Hole...

read more

August 25, 2025 Stocks On The Move

Stocks moving today: Intel, Keurig Dr Pepper, Wayfair, Strategy, Nvidia, Vital Energy The stocks moving today include Intel, Wayfair, Keurig Dr Pepper, Strategy, Nvidia, and Vital Energy. Headlines span government stakes, tariff probes, big acquisitions, Bitcoin...

read more

Palantir CEO Alex Karp Stock Sale

Palantir CEO Alex Karp stock sale: price impact and a day-trading playbook A new Palantir CEO, Alex Karp, stock sale disclosed via Form 4 shows 409,072 shares sold last week (automatic transactions tied to tax withholding on vested RSUs) at ~$142.46–$157.56. PLTR...

read more

NIO stock soars on ES8 launch

NIO Stock Soars on ES8 Launch (Aug 2025) A cheaper ES8 with Battery‑as‑a‑Service, the new L90, and improving deliveries have investors re‑rating NIO. Here’s what changed—and how to trade it. What’s New · Why It Matters · Delivery Momentum · Rivals & Price War ·...

read more

US Stablecoin Rules Deposit Outflows

US stablecoin rules deposit outflows — the fight over a “yield” loophole Bank trade groups want Congress to amend the new GENIUS Act because they say a loophole lets exchanges indirectly pay interest on third-party stablecoins. They argue that this could trigger US...

read more

xAI lawsuit against Apple and OpenAI

xAI lawsuit against Apple and OpenAI over ChatGPT–iPhone integration Elon Musk’s xAI filed a federal antitrust complaint in Texas alleging that Apple’s integration of ChatGPT into iPhones and App Store promotion practices unfairly disadvantage rivals like Grok. Apple...

read more

Nvidia Jetson AGX Thor Robot Brain

Nvidia Jetson AGX Thor Robot Brain: A Fresh Catalyst for NVDA Nvidia’s new Nvidia Jetson AGX Thor robot brain platform—built on Blackwell—arrives with developer kits at $3,499 and production Jetson T5000 modules for scaled deployments. What launched—and why it matters...

read more

Tesla Stock Soars on Rate‑Cut Hopes

Tesla Stock Soars on Rate‑Cut Hopes (Aug 2025) Powell’s Jackson Hole remarks pushed rate‑cut odds higher and lifted risk assets—TSLA included. Meanwhile, Tesla’s new Cybertruck Luxe Package grabbed headlines but remains a sideshow to the rates story. Overview · Rates...

read more

Nvidia Earnings and PCE Inflation Gauge

Week Ahead: Nvidia earnings and PCE inflation gauge (Aug 25–29, 2025) In the wake of Fed Chair Jerome Powell’s Jackson Hole remarks, markets face a packed slate of economic data and high‑impact earnings—headlined by the Fed’s preferred inflation measure and Nvidia’s...

read more

Japanese Stocks Soar Despite Tariffs

Japanese Stocks Soar Despite Tariffs and Turmoil (Aug 2025) EWJ and key indices in Tokyo keep climbing even as the U.S. locks in 15% reciprocal tariffs and Japan’s ruling coalition loses its upper‑house majority. Here’s what’s driving the rally—and how to trade it....

read more

Fast vs. Reflective Decisions in Trading

The MTRI Impulsivity Dimension: Fast vs. Reflective Decisions in Trading Our background in behavioral finance has had Traderinsight.com focused on the psychological development of traders for three decades.  It's only a recent evolution that has media outlets like...

read more

Estée Lauder Stock Plummets

Estée Lauder Stock Plummets: Weak Guidance Spooks Investors Estée Lauder stock (EL) plummets after the cosmetics giant reported in-line earnings but issued soft guidance for the fiscal year ahead. Despite adjusted EPS of $0.09 on revenue of $3.41B—both in line with...

read more

Target CEO Change Overshadows Earnings

Target CEO Change Overshadows Earnings: What Day Traders Should Watch Target posted a slight Q2 beat, but price action says the leadership shift is the real catalyst. Here’s how to trade the reaction—because in the short term, Target CEO change overshadows earnings....

read more

Meme Stock Pump-and-Dump Scams

Meme Stock Pump-and-Dump Scams: A Day Trader’s Survival Guide In July, a fresh wave of meme-stock “ramps” rocketed thinly traded microcaps before collapsing just as fast—leaving billions in paper wealth erased and a trail of retail accounts blown up. Here’s what...

read more

Advance Auto Parts Earnings Day Trading Setup

Advance Auto Parts (AAP) After Earnings: A Deeper Dive and Day-Trading Playbook Advance Auto Parts posted an EPS beat but guided 2025 lower as interest expense rises following a $1.95B notes offering. The stock’s third straight double-digit post-earnings move makes...

read more

Oracle Earnings Day Trading Setup

Oracle’s AI Rally Pauses: A Deeper Dive with Day-Trading Setups Oracle (ORCL) slipped more than 4% to ~238 after a torrid June–July run that peaked at 260.87. Price is now decisively below the 21-day moving average while still hovering a few percent above the 50-day,...

read more

Merck Keytruda Medicare Delay

A Tweak to Medicare is Good for Merck. But Can It Revive the Stock? Merck & Co. has found a small reprieve in Washington, but investors remain skeptical that it will meaningfully alter the company’s trajectory. A new tweak to Medicare’s drug price negotiation...

read more

September Fed rate cut and day trading

September Fed Rate Cut: Why Day Traders Should Prepare for a Hawkish Surprise Fed expectations vs. market reality The S&P 500, currently hovering above 6400, has rallied on expectations of a September Fed rate cut. Fed funds futures are pricing an 85% chance of a...

read more

Novo Nordisk Wegovy MASH approval

Novo Nordisk Wegovy MASH approval: Why NVO is jumping—and how day traders can trade it Quick take Novo Nordisk shares pop after the FDA grants accelerated approval for Wegovy to treat MASH (metabolic dysfunction-associated steatohepatitis) with liver fibrosis in...

read more

DeepSeek AI Model Delay

DeepSeek’s AI Model Delay and the Impact on Intraday Trading Opportunities China’s AI Ambitions Face Technical Headwinds The delay in the DeepSeek AI model underscores a significant challenge in Beijing’s push to reduce reliance on U.S. technology. The Chinese AI...

read more

Weight-Loss Drug Stocks

Weight-Loss Drug Stocks and Day Trading Opportunities Pharma’s Former Darling Turns Volatile The meteoric rise of weight-loss drug stocks such as Novo Nordisk and Eli Lilly was once seen as a safe haven in the pharmaceutical sector. Fueled by the popularity of GLP-1...

read more

Common Questions About The Doctors Dose

What topics are covered in The Doctors Dose?

The Doctors Dose includes a wide range of topics such as market analysis, trading strategies, and expert insights to help you make informed trading decisions.

How often is new content added to The Doctors Dose?

New articles and insights are added daily, ensuring you have the latest information and strategies at your fingertips.

Who writes for The Doctors Dose?

Our content is crafted by seasoned traders and financial experts who share their knowledge and experience to empower our readers.

Can I suggest topics for The Doctors Dose?

Absolutely! We welcome suggestions from our readers. Feel free to contact us with your ideas and feedback.

Is The Doctors Dose suitable for beginners?

Yes, we provide content that caters to all levels, from beginners to advanced traders, ensuring everyone can benefit from our insights.

Explore More with TraderInsight

Unlock a wealth of knowledge and take your trading skills to the next level with TraderInsight.academy. Dive into our expert resources and start your journey towards successful trading today.